John P. Pablo, Ph.D. - Publications

Affiliations: 
2000 University of Miami, Coral Gables, FL 
Area:
Neuroscience Biology, Pharmacology, Rehabilitation and Therapy

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Mondo K, Hammerschlag N, Basile M, Pablo J, Banack SA, Mash DC. Cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) in shark fins. Marine Drugs. 10: 509-20. PMID 22412816 DOI: 10.3390/Md10020509  0.476
2010 Brand LE, Pablo J, Compton A, Hammerschlag N, Mash DC. Cyanobacterial Blooms and the Occurrence of the neurotoxin beta-N-methylamino-L-alanine (BMAA) in South Florida Aquatic Food Webs. Harmful Algae. 9: 620-635. PMID 21057660 DOI: 10.1016/J.Hal.2010.05.002  0.49
2009 Mash DC, Duque L, Pablo J, Qin Y, Adi N, Hearn WL, Hyma BA, Karch SB, Druid H, Wetli CV. Brain biomarkers for identifying excited delirium as a cause of sudden death. Forensic Science International. 190: e13-9. PMID 19541436 DOI: 10.1016/J.Forsciint.2009.05.012  0.539
2009 Pablo J, Banack SA, Cox PA, Johnson TE, Papapetropoulos S, Bradley WG, Buck A, Mash DC. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease. Acta Neurologica Scandinavica. 120: 216-25. PMID 19254284 DOI: 10.1111/J.1600-0404.2008.01150.X  0.49
2008 Mash DC, Adi N, Duque L, Pablo J, Kumar M, Ervin FR. Alpha synuclein protein levels are increased in serum from recently abstinent cocaine abusers. Drug and Alcohol Dependence. 94: 246-50. PMID 18055133 DOI: 10.1016/J.Drugalcdep.2007.09.020  0.563
2007 Mash DC, ffrench-Mullen J, Adi N, Qin Y, Buck A, Pablo J. Gene expression in human hippocampus from cocaine abusers identifies genes which regulate extracellular matrix remodeling. Plos One. 2: e1187. PMID 18000554 DOI: 10.1371/Journal.Pone.0001187  0.565
2006 Papapetropoulos S, Ffrench-Mullen J, McCorquodale D, Qin Y, Pablo J, Mash DC. Multiregional gene expression profiling identifies MRPS6 as a possible candidate gene for Parkinson's disease. Gene Expression. 13: 205-15. PMID 17193926 DOI: 10.3727/000000006783991827  0.483
2005 Qin Y, Ouyang Q, Pablo J, Mash DC. Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in the human striatum. Neuroreport. 16: 1489-93. PMID 16110277 DOI: 10.1097/01.Wnr.0000175617.39054.Ba  0.568
2005 Mash DC, Ouyang Q, Qin Y, Pablo J. Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers. Journal of Neuroscience Methods. 143: 79-85. PMID 15763139 DOI: 10.1016/J.Jneumeth.2004.09.013  0.588
2003 Mash DC, Ouyang Q, Pablo J, Basile M, Izenwasser S, Lieberman A, Perrin RJ. Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 2564-71. PMID 12684441  0.527
2003 Mash DC, Ouyang Q, Pablo J, Basile M, Izenwasser S, Lieberman A, Perrin RJ. Cocaine Abusers Have an Overexpression of α-Synuclein in Dopamine Neurons The Journal of Neuroscience. 23: 2564-2571. DOI: 10.1523/Jneurosci.23-07-02564.2003  0.565
2002 Mash DC, Pablo J, Ouyang Q, Hearn WL, Izenwasser S. Dopamine transport function is elevated in cocaine users. Journal of Neurochemistry. 81: 292-300. PMID 12064476 DOI: 10.1046/J.1471-4159.2002.00820.X  0.599
2001 Baumann MH, Pablo J, Ali SF, Rothman RB, Mash DC. Chapter 5 Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine Alkaloids: Chemistry and Biology. 56: 79-113. PMID 11705118 DOI: 10.1016/S0099-9598(01)56009-5  0.574
2001 Mash DC, Kovera CA, Pablo J, Tyndale R, Ervin FR, Kamlet JD, Hearn WL. Ibogaine in the treatment of heroin withdrawal. The Alkaloids. Chemistry and Biology. 56: 155-71. PMID 11705106 DOI: 10.1016/S0099-9598(01)56012-5  0.517
2001 Baumann MH, Rothman RB, Pablo JP, Mash DC. In vivo neurobiological effects of ibogaine and its O-desmethyl metabolite, 12-hydroxyibogamine (noribogaine), in rats. The Journal of Pharmacology and Experimental Therapeutics. 297: 531-9. PMID 11303040  0.492
2000 Mash DC, Kovera CA, Pablo J, Tyndale RF, Ervin FD, Williams IC, Singleton EG, Mayor M. Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures. Annals of the New York Academy of Sciences. 914: 394-401. PMID 11085338 DOI: 10.1111/J.1749-6632.2000.Tb05213.X  0.536
2000 Baumann MH, Pablo JP, Ali SF, Rothman RB, Mash DC. Noribogaine (12-hydroxyibogamine): a biologically active metabolite of the antiaddictive drug ibogaine. Annals of the New York Academy of Sciences. 914: 354-68. PMID 11085335 DOI: 10.1111/J.1749-6632.2000.Tb05210.X  0.557
1999 Zubaran C, Shoaib M, Stolerman IP, Pablo J, Mash DC. Noribogaine generalization to the ibogaine Stimulus: Correlation with noribogaine concentration in rat brain Neuropsychopharmacology. 21: 119-126. PMID 10379526 DOI: 10.1016/S0893-133X(99)00003-2  0.53
1999 Basile DV, Punch MS, Pablo J, Brenner B, Hearn WL, Mash DC. Indole alkaloids from tissue-cultured Tabernanthe iboga H. Bn Natural Product Letters. 13: 233-238. DOI: 10.1080/10575639908048791  0.494
1998 Pablo JP, Mash DC. Noribogaine stimulates naloxone-sensitive [35S]GTPgammaS binding. Neuroreport. 9: 109-14. PMID 9592058 DOI: 10.1097/00001756-199801050-00022  0.52
1996 Staley JK, Ouyang Q, Pablo J, Hearn WL, Flynn DD, Rothman RB, Rice KC, Mash DC. Pharmacological screen for activities of 12-hydroxyibogamine: A primary metabolite of the indole alkaloid ibogaine Psychopharmacology. 127: 10-18. PMID 8880938 DOI: 10.1007/Bf02805969  0.571
1995 Hearn WL, Pablo J, Hime GW, Mash DC. Identification and quantitation of ibogaine and an o-demethylated metabolite in brain and biological fluids using gas chromatography-mass spectrometry. Journal of Analytical Toxicology. 19: 427-34. PMID 8926737 DOI: 10.1093/Jat/19.6.427  0.474
1995 Mash DC, Staley JK, Pablo JP, Holohean AM, Hackman JC, Davidoff RA. Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex. Neuroscience Letters. 192: 53-6. PMID 7675310 DOI: 10.1016/0304-3940(95)11608-Y  0.507
1991 Mash DC, Pablo J, Buck BE, Sanchez-Ramos J, Weiner WJ. Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated mice Experimental Neurology. 114: 73-81. PMID 1915737 DOI: 10.1016/0014-4886(91)90086-R  0.529
1990 Mash DC, Pablo J, Flynn DD, Efange SMN, Weiner WJ. Characterization and distribution of transferrin receptors in the rat brain Journal of Neurochemistry. 55: 1972-1979. PMID 2230804 DOI: 10.1111/J.1471-4159.1990.Tb05784.X  0.528
1990 Efange SM, Kung HF, Mash DC, Jabir M, Billings J, Pablo J, Dutta A, Freshler A. Pargyline-sensitive selective accumulation of a radiolabeled MPTP analog in the primate cerebral cortex and basal ganglia. Synapse (New York, N.Y.). 5: 207-12. PMID 2111588 DOI: 10.1002/Syn.890050306  0.527
Show low-probability matches.